PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · South Asian J Cancer 2017; 06(04): 139-140
DOI: 10.4103/sajc.sajc_58_17
Original Article : Bone & Soft Tissue Tumors

Role of percutaneous computed tomography-guided radiofrequency ablation in treatment of osteoid osteoma

Ajay R. Upadhyay
Department of Radiodiagnosis, GCS Medical College, Hospital and Research Center, Ahmedabad, Gujarat
,
Nikunj Chandrakant Desai
Department of Radiodiagnosis, GCS Medical College, Hospital and Research Center, Ahmedabad, Gujarat
,
Digish U. Vaghela
Department of Radiodiagnosis, B. J. Medical College and New Civil Hospital, Ahmedabad, Gujarat
› Author Affiliations
Source of Support: Nill.
› Further Information
Also available ateRef
 PDF Download Permissions and Reprints
Preview

Abstract

Aim: The aim of the study was to evaluate efficacy of percutaneous computed tomography (CT)-guided radiofrequency ablation (RFA) of nidus in osteoid osteoma (OO). Materials and Methods: RFA was performed on fifty patients with clinically and radiologically diagnosed OO. RFA was done in the department of radio-diagnosis in our institute (a tertiary care providing institute in Ahmedabad, Western India). Ablation was performed by putting at an electrode tip (3–5 mm) into nidus under CT guidance with targeted temperature of 90°C for 3 min. Results: All procedures were technically successful. No immediate major or minor complications were observed. Complete clinical success was achieved in 46 patients. Only four patients required second intervention. Conclusion: Our experience indicates a 98% success rate. No major complications were noted.

Key words

Ablation - computed tomography - osteoid osteoma


Publication History

Article published online:
22 December 2020

© 2017. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Motamedi D, Learch TJ, Ishimitsu DN, Motamedi K, Katz MD, Brien EW, et al. Thermal ablation of osteoid osteoma: Overview and step-by-step guide. Radiographics 2009;29:2127-41.
  • 2 Asayama Y, Nishie A, Ishigami K, Kakihara D, Ushijima Y, Takayama Y, et al. CT-guided radiofrequency ablation of osteoid osteoma in the long bones of the lower extremity. World J Radiol 2012;4:278-82.
  • 3 Sung KS, Seo JG, Shim JS, Lee YS. Computed-tomography-guided percutaneous radiofrequency thermoablation for the treatment of osteoid osteoma-2 to 5 years follow-up. Int Orthop 2009;33:215-8.
  • 4 Jankharia B, Burute N. Percutaneous radiofrequency ablation for osteoid osteoma: How we do it. Indian J Radiol Imaging 2009;19:36-42.
  • 5 Kjar RA, Powell GJ, Schilcht SM, Smith PJ, Slavin J, Choong PF. Percutaneous radiofrequency ablation for osteoid osteoma: Experience with a new treatment. Med J Aust 2006;184:563-5.
  • 6 Cantwell CP, Obyrne J, Eustace S. Current trends in treatment of osteoid osteoma with an emphasis on radiofrequency ablation. Eur Radiol 2004;14:607-17.
  • 7 Lindner NJ, Ozaki T, Roedl R, Gosheger G, Winkelmann W, Wörtler K. Percutaneous radiofrequency ablation in osteoid osteoma. J Bone Joint Surg Br 2001;83:391-6.
  • 8 Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ. Osteoid osteoma: Percutaneous treatment with radiofrequency energy. Radiology 2003;229:171-5.
  • 9 Maurer MH, Gebauer B, Wieners G, De Bucourt M, Renz DM, Hamm B, et al. Treatment of osteoid osteoma using CT-guided radiofrequency ablation versus MR-guided laser ablation: A cost comparison. Eur J Radiol 2012;81:e1002-6.
  • 10 Yip PS, Lam YL, Chan MK, Shu JS, Lai KC, So YC. Computed tomography-guided percutaneous radiofrequency ablation of osteoid osteoma: Local experience. Hong Kong Med J 2006;12:305-9.